Bradley J. Stish, MD

Articles by Bradley J. Stish, MD

Optimizing Oxybutynin Doses for ADT-Induced Hot Flashes in Prostate Cancer

April 2nd 2026

Bradley J. Stish, MD, emphasized the role of decision-making processes between physicians and patients when deciding between 2.5 and 5 mg of oxybutynin.

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Brexucabtagene Autoleucel in Adult R/R MCL

Discussing a Phase 2 Defactinib/Avutometinib Trial in Diffuse Gastric Cancer

The Rise of Early-Onset Cancers: Investigating Breast and CRC Occurrences

Anbenitamab Injection Combo Meets pCR End Point in HER2+ Breast Cancer

Highlighting Emerging Genitourinary Cancer Research at Columbia University